NBS-nytt
12.06.2017
Tuberculosis (TB), the human disease caused by Mycobacterium tuberculosis that has killed many millions of people during at least the last 200 years, is still with us. Researchers at NMBU are making progress on a TB-vaccine based on surface antigen presentation on cells of Lactobacillus plantarum (1).
According to the World Health Organization (WHO), over 10 million people become ill with TB every year, resulting in about 2 million deaths. TB is one of the top 10 causes of death worldwide, ahead of both malaria and AIDS. An international project coordinated by WHO has as its goal a 90% reduction in world TB deaths by the year 2030. To accomplish this, new antibiotics are being screened for TB treatment and at least 13 different projects for TB vaccine development are ongoing worldwide (2). The socalled bacille Calmette-Guerin vaccine (BCG) for TB, based on an attenuated form of Mycobacterium bovis, was developed over 100 years ago but it is
Gå til mediet
